CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $14.84B, above the global median of $1.14B
- FinancialsAltman Z-Score 8.13: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
14.84BUSDvs all stocks (USD)
Trailing P/E
21.41xRevenue (TTM)
3.37BUSDvs all stocks (USD)
Profit Margin
20.91%Beta
0.4000xvs all stocks
52-Week Change
5.78%vs all stocks
Market Capitalization
14.84BUSDvs all stocks (USD)
Enterprise Value
14.91BUSDvs all stocks (USD)
Trailing P/E
21.41xForward P/E
12.19xPEG Ratio
0.6863xPrice to Sales (TTM)
4.40xPrice to Book (MRQ)
4.02xEnterprise to Revenue
4.42xEnterprise to EBITDA
16.33xGross Margin
97.58%Profit Margin
20.91%Operating Margin
22.19%Return on Assets (TTM)
11.70%Return on Equity (TTM)
22.09%Revenue (TTM)
3.37BUSDvs all stocks (USD)
Revenue per Share (TTM)
33.66USDUpdated Oct 28, 2026Quarterly Revenue Growth
39.50%Gross Profit (TTM)
2.18BUSDvs all stocks (USD)
EBITDA (TTM)
819.00MUSDvs all stocks (USD)
Net Income (TTM)
705.50MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
34.30%Operating Cash Flow (TTM)
898.10MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
638.24MUSDvs all stocks (USD)
Payout Ratio
0.00%Revenue
2.86BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
52.10MUSDFY2025 · Dec 31, 2025Gross Profit
2.81BUSDFY2025 · Dec 31, 2025Operating Income
636.50MUSDvs all stocks (USD)
Pre-tax Income
705.40MUSDFY2025 · Dec 31, 2025Income Tax Expense
226.80MUSDFY2025 · Dec 31, 2025Net Income
478.60MUSDFY2025 · Dec 31, 2025EBIT
636.50MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
688.00MUSDFY2025 · Dec 31, 2025Research & Development
1.02BUSDFY2025 · Dec 31, 2025Selling, General & Administrative
1.16BUSDFY2025 · Dec 31, 2025Non-operating Interest Income
90.30MUSDFY2025 · Dec 31, 2025EPS (Basic)
4.81USDFY2025 · Dec 31, 2025EPS (Diluted)
4.67USDFY2025 · Dec 31, 2025Basic Shares Outstanding
99.50MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
99.50MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
478.60MUSDFY2025 · Dec 31, 2025Operating Cash Flow
617.80MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
721.00MUSDFY2025 · Dec 31, 2025Income Tax Paid
81.40MUSDFY2025 · Dec 31, 2025Interest Paid
0.00USDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
478.60MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
30.10MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
165.40MUSDFY2025 · Dec 31, 2025Stock-based Compensation
217.90MUSDFY2025 · Dec 31, 2025Other Non-cash Items
14.80MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-210.50MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-78.50MUSDFY2025 · Dec 31, 2025Purchase of Investments
-1.32BUSDFY2025 · Dec 31, 2025Sale of Investments
1.09BUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-230.40MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
0.00USDFY2025 · Dec 31, 2025Common Stock Repurchase
-167.70MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-167.70MUSDFY2025 · Dec 31, 2025Shares Outstanding
101.60MSharesUpdated Oct 28, 2026Float Shares
100.35MSharesUpdated Oct 28, 2026Shares Short
5.85MSharesUpdated Oct 28, 2026Short Ratio
4.67daysvs all stocks
Short % of Shares Outstanding
7.48%vs all stocks
% Held by Insiders
1.06%vs all stocks
% Held by Institutions
103.62%vs all stocks
Total Cash (MRQ)
389.80MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
3.83USDUpdated Oct 28, 2026Total Debt (MRQ)
461.60MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.1250xCurrent Ratio (MRQ)
1.87xBook Value per Share (MRQ)
36.35USDUpdated Oct 28, 2026Total Assets
4.63BUSDvs all stocks (USD)
Total Current Assets
2.52BUSDFY2025 · Dec 31, 2025Total Liabilities
1.38BUSDFY2025 · Dec 31, 2025Total Non-current Assets
2.11BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
635.00MUSDFY2025 · Dec 31, 2025Total Current Liabilities
743.40MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
713.00MUSDFY2025 · Dec 31, 2025Other Short-term Investments
767.40MUSDFY2025 · Dec 31, 2025Accounts Receivable
686.80MUSDFY2025 · Dec 31, 2025Inventory
69.00MUSDFY2025 · Dec 31, 2025Accounts Payable
104.90MUSDFY2025 · Dec 31, 2025Other Current Liabilities
69.10MUSDFY2025 · Dec 31, 2025Long-term Debt
415.30MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
5.20MUSDFY2025 · Dec 31, 2025Common Stock (Book)
100.00KUSDFY2025 · Dec 31, 2025Retained Earnings
447.70MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
3.25BUSDvs all stocks (USD)
52-Week Low
122.14USDUpdated Oct 28, 202652-Week High
186.12USDUpdated Oct 28, 202652-Week Change
5.78%vs all stocks
Beta
0.4000xvs all stocks
50-Day MA
147.30USDUpdated Oct 28, 2026200-Day MA
147.14USDUpdated Oct 28, 2026Avg 10-Day Volume
1.18MSharesUpdated Oct 28, 2026Avg 30-Day Volume
1.37MSharesUpdated Oct 28, 2026Diluted EPS (TTM)
6.82USDUpdated Oct 28, 2026Other Income / Expense
-21.40MUSDFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 8.13: safe zoneNotable
Altman Z-Score: 8.13
High earnings qualityNotable
Earnings Quality Score: 0.92
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $14.84B, above the global median of $1.14BNotable
Market cap (USD): 14,840,780,426Global Median: 1,138,450,684.034
Revenue is $3.37B, above the global median of $562.3MNotable
Revenue (USD): 3,373,900,032Global Median: 562,304,852.367
Levered free cash flow is $638.24M, above the global median of $18.69MNotable
Levered free cash flow (USD): 638,237,504Global Median: 18,689,872.41
Companies that share the same coordination system — how they create, deliver, or capture value.
Halozyme Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Yunnan Baiyao Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Ipsen S.A.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai United Imaging Healthcare Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Sino Biopharmaceutical Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Exelixis Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jazz Pharmaceuticals plc
Tier 1ProductionApproval-Gated PipelineRuleRisk
BridgeBio Pharma, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sichuan Biokin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Penumbra Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Guangxi Huaxi Nonferrous Metals Co. Ltd.
2 interpretationsOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income Growth
Sunny Loan Top Co. Ltd.
2 interpretationsOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income Growth
Chifeng Jilong Gold Mining Co., Ltd.
2 interpretationsOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income Growth